Skip to main content
SpringerLink
Log in

Macrolide antibiotics

  • Basic and Behavioural Sciences
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

This article is an extensive review of current information available on the macrolide antibiotics. This includes antimicrobial spectrum, pharmacology, complications and side effects, and pediatric use of these drugs. These are important antibiotics, but careful selection of patients must be made and the physician must be alert for evidence of drug-drug interactions, which are not uncommon with several members of this class.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Long SS, Pickering LK, Prober CG (Eds.)Principles and Practice of Pediatric Infectious Diseases. New York: Churchill-Livingston, 1977; 1622–1626, 1636–1637.

    Google Scholar 

  2. Moriyasu H, Oita J, Minematsu K. Erythromycin-induced hearing loss in a patient withListeria monocytogenes meningo-ventriculitis.Rinsho Shinkeigaku 1966; 36: 1107–1109.

    Google Scholar 

  3. Hardy DJ. Extent and spectrum of the antimicrobial activity of clarithromycin.Pediatr Inf Dis J 1993; 12: S99–105.

    Article  Google Scholar 

  4. Tyndall MW, Agoki E, Plummer FA,et al. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin.Sex Transm Dis 1994; 21: 231–234.

    Article  PubMed  CAS  Google Scholar 

  5. Martin DH, Sargent SJ, Wendel GD, Jr.et al. Comparison of azithromycin and ceftriaxone for the treatment of chancroid.Clin Infect Dis 1995; 21: 409–414.

    PubMed  CAS  Google Scholar 

  6. Luft BJ, Dattwyler RJ, Johnson RC,et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans.Ann Intern Med 1996; 124: 785–791.

    PubMed  CAS  Google Scholar 

  7. Committee On Infectious Diseases.American Academy of Pediatrics Red Book. 24th Ed. Lyme Disease, Elk Grove Village, IL 1997;329–333.

  8. Pierce M, Crampton S, Henry D,et al. A randomized trial of clarithromycin as prophylaxis against disseminatedMycobacterium Avium-Intracellulare infection in patients with advanced acquired immunodeficiency syndrome.NEJM 1996; 335: 384–391.

    Article  PubMed  CAS  Google Scholar 

  9. Pfizer Product Information. Physicians Desk Reference 51/1997.Montvale, NJ: Medical Economics Company, 1997; 2050.

    Google Scholar 

  10. Hoppe JE, Eichorn A. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.Eur J Clin Microbiol Inf Dis. 1989; 8: 653–654.

    Article  CAS  Google Scholar 

  11. Aoyama T, Sunakawa K, Iwata S,et al. Efficacy of short-term treatment of pertussis with ìclarithromycin and azithromycin.J Pediatr 1996; 129: 761–764.

    Article  PubMed  CAS  Google Scholar 

  12. Powers JL. Properties of azithromycin that enhance the potential for compliance in children ìwith upper respiratory tract infections.Pediatr Inf Dis J 1966; 15: S30-S37.

    Article  Google Scholar 

  13. Foulds G, Luke DR, Teng R,et al. The absence of an effect of food on the bioavailability of ìazithromycin administered as tablets, sachet or suspension.J Antimicrob Chemother 1996; 37 (Suppl CP): 37–44.

    PubMed  CAS  Google Scholar 

  14. Wintermeyer SM, Abdel-Rahman SM, Nahata MC. Dirithromycin: a new macrolide.Ann Pharmacother 1996; 30: 1141–1149. ìè 15. Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, ìpharmacokinetic properties and therapeutic use.Drugs 1994; 48: 297–236.

    PubMed  CAS  Google Scholar 

  15. Gemmell CG. Macrolides and host defences to respiratory tract pathogens.J Hosp Inf 1991; 19 (Suppl AP) 11–19.

    Article  Google Scholar 

  16. Agen C, Danesi R, Blandizzi C,et al. Macrolide antibiotics as antiinflammatory agents: ìroxithromycin in an unexpected role.Agents Actions 1993; 38: 85–90.

    Article  PubMed  CAS  Google Scholar 

  17. Shimizu, T, Kato M, Mochizuki, H,et al. Roxithromycin attenuates acid-induced cough and water-induced broncho-constriction in children with asthma.J Asthma 1997; 34: 211–217.

    Article  PubMed  CAS  Google Scholar 

  18. Lozano R, Balaguer A. Josamycin in the treatment of bronchopulmonary infections.Clin Ther 1991; 13: 281–288.

    PubMed  CAS  Google Scholar 

  19. Jackson MA, Burry VB, Olson LC,et al. Breakthrough sepsis in macrolide-resistant pneumococcal infection.Pediatr Inf Dis J 1996; 15: 1049–1051.

    Article  CAS  Google Scholar 

  20. Myburgh J, Nagel GJ, Petschel E. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia.J Antimicrob Chemother 1993; June 31 Suppl EP: 163–169.

    Google Scholar 

  21. Uzun O, Akova M, Gur D,et al. Efficacy of a three day course of azithromycin in the treatment of community-acquired pneumonia. Preliminary report.J Chemother 1994; 6: 53–57.

    PubMed  CAS  Google Scholar 

  22. Schwartz MN. Editorial. Use of antimicrobial agents and drug resistance.NEJM 1997; 337: 491–492

    Article  Google Scholar 

  23. Seppala H, Klaukka F, Vuopio-Varkila J,et al. The effect of changes in the consumption of ìmacrolide antibiotics on erythromycin resistance in group A streptococci in Finland.NEJM 1997; 337: 441–446.

    Article  PubMed  CAS  Google Scholar 

  24. Nahata M. Drug interactions with azithromycin and the macrolides: an overview.J Antimicrob Chemother 1996; 37 (Suppl CP): 133–142.

    PubMed  CAS  Google Scholar 

  25. Pereti P, Mazzei T, Mini E,et al. Adverse effects of macrolide antimicrobials.Drug Saf 1993; 9: 346–364.

    Article  Google Scholar 

  26. Brown BA, Wallace RJ, Griffith DE. Clarithromycin induced hepatotoxicity.Clin ID 1995; 20: 1073.

    CAS  Google Scholar 

  27. Shaheen N, Grimm IS. Fulminant hepatic failure associated with clarithromycin.Am J Gastroent 1996; 91: 394–395.

    PubMed  CAS  Google Scholar 

  28. Liviu L, Yair L, Yehuda S. Pancreatitis induced by clarithromycin (letter).Ann Intern Med 1996; 125: 701.

    PubMed  CAS  Google Scholar 

  29. Oteo JA, Gomez-Cadieanos RA, Rosel L. Clarithromycin induced thrombocytopenia.Clin ID 1994; 19: 1170.

    CAS  Google Scholar 

  30. Steinman MA, Steinman TI. Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis.Am J Kidney Dis 1996; 127: 143–146.

    Google Scholar 

  31. Cadisch R, Streit E, Hartman K. Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax).Schweiz Med Wochenschr 1996; 126: 308–310.

    PubMed  CAS  Google Scholar 

  32. Gomez E, Sanchez JE, Aguado S,et al. Interaction between azithromycin and cyclosporin?Nephron 1996; 73: 724.

    PubMed  CAS  Google Scholar 

  33. Jacobs K. Clinical efficacy of dirithromycin in pneumonia.J Antimicrob Chemother. 1993; 31 (Suppl CP): 121–129.

    Google Scholar 

  34. Souweine B, Fialip J, Ruivard M,et al. Acute pancreatitis associated with roxithromycin ìtherapy (letter).DICP 1991; 25: 1137.

    PubMed  CAS  Google Scholar 

  35. Delcourt A, Lambert M, Geubel A. Reversible liver injury possibly due to roxithromycin ìtherapy.Acta Clin Belg 1990; 45: 206–207.

    PubMed  CAS  Google Scholar 

  36. Billaud EM, Guillemain R, Fortineau N,et al. Interaction between roxithromycin and cyclosporin in heart transplant patients.Clin Pharmacokinet 1990; 19: 499–502.

    PubMed  CAS  Google Scholar 

  37. Backman JT, Aranko K, Himberg JJ,et al. A pharmacokinetic interaction between roxithromycin and midazolam.Eur J Clin Pharmacol 1994; 46: 551–555.

    Article  PubMed  CAS  Google Scholar 

  38. Yeates RA, Laufen H, Zimmermann T. Interaction between midazolam and clarithromycin: ìcomparison with azithromycin.Int J Clin Pharmacol Ther 1996; 34: 400–405.

    PubMed  CAS  Google Scholar 

  39. Azanza JR, Catalan M, Alvarez MP,et al. Possible interaction between cyclosporin and josamycin: a description of three cases.Clin Pharmacol Ther 1992; 51: 72–575.

    Article  Google Scholar 

  40. Bosch X, Pedrol E, Casado X,et al. Josamycin-induced pedal oedema.BMJ 1993; 307 (6895): 26.

    PubMed  CAS  Google Scholar 

  41. Nahata M. Drug interactions with azithromycin and the macrolides: an overview.J Antimicrob Chemother 1996; 37 Suppl CP: 133–142.

    PubMed  CAS  Google Scholar 

  42. Von Rosensteil NA, Adam D, Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf 1995; 13: 105–122.

    Article  Google Scholar 

  43. Gordon RC.Listeria monocytogenes infections.Indian J Pediatr 1995; 62: 33–39

    Article  PubMed  CAS  Google Scholar 

  44. Mashkilleyson AL, Gomberg MA, Mashkilleyson N,et al. Treatment of syphilis with azithromycin.Int J STD AIDS 1996; 7 (Suppl 1P): 13–15.

    Article  PubMed  Google Scholar 

  45. Khan WA, Seas C, Dhar U,et al. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double blind, randomized, controlled trial.Ann Intern Med 1997; 126: 697–703.

    PubMed  CAS  Google Scholar 

  46. Dohil R, Israel DM, Hassall E. Effective 2-wk therapy for Helicobacter pylori disease in children.Am J Gastroenterol 1997; 92: 244–247.

    PubMed  CAS  Google Scholar 

  47. Bourke B, Jones N, Sherman P. Helicobacter infection and peptic ulcer disease in children.Pediatr Infect Dis J 1996; 15: 1–13.

    Article  PubMed  CAS  Google Scholar 

  48. Freeman HJ. Disappearance of Helicobacter without antibiotics in 12 patients with gastritis.AADE Ed J. 1997; 11: 167–172.

    CAS  Google Scholar 

  49. Teare JP, booth JC, Brown JL,et al. Pseudomembranous colitis following clarithromycin therapy.AADE Ed J. 1995; 7: 275–277.

    CAS  Google Scholar 

  50. Anonymous. New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 1996 and New Indications for Previously Approved Agents.Antimicrob Agents & Chemother, 1997; 41: 878.

  51. Bedford TA, Rowbotham DJ. Cisapride. Drug interactions of clinical significance.Drug Saf 1996; 15: 167–175.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics and Human Development, College of Human Medicine, Michigan State University, USA

    Ralph C. Gordon (Professor of Pediatrics & Human Development MSU)

Authors
  1. Ralph C. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, R.C. Macrolide antibiotics. Indian J Pediatr 65, 1–9 (1998). https://doi.org/10.1007/BF02849685

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02849685

Key words

Search

Navigation